Chemoinformaics analysis of 1-HYDROXY-3-METHOXY-10-METHYLACRIDONE
| Molecular Weight | 255.273 | nRot | 1 |
| Heavy Atom Molecular Weight | 242.169 | nRig | 17 |
| Exact Molecular Weight | 255.09 | nRing | 3 |
| Solubility: LogS | -3.864 | nHRing | 1 |
| Solubility: LogP | 2.925 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 16 |
| nHA | 4 | APOL | 37.2243 |
| nHD | 1 | BPOL | 17.3557 |
| QED | 0.679 |
| Synth | 2.108 |
| Natural Product Likeliness | 0.619 |
| NR-PPAR-gamma | 0.51 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.005 |
| HIA | 0.01 |
| CACO-2 | -4.835 |
| MDCK | 0.0000233 |
| BBB | 0.531 |
| PPB | 0.945751 |
| VDSS | 0.869 |
| FU | 0.0322294 |
| CYP1A2-inh | 0.985 |
| CYP1A2-sub | 0.952 |
| CYP2c19-inh | 0.831 |
| CYP2c19-sub | 0.4 |
| CYP2c9-inh | 0.669 |
| CYP2c9-sub | 0.937 |
| CYP2d6-inh | 0.757 |
| CYP2d6-sub | 0.907 |
| CYP3a4-inh | 0.391 |
| CYP3a4-sub | 0.201 |
| CL | 2.935 |
| T12 | 0.291 |
| hERG | 0.024 |
| Ames | 0.849 |
| ROA | 0.071 |
| SkinSen | 0.611 |
| Carcinogencity | 0.895 |
| EI | 0.965 |
| Respiratory | 0.803 |
| NR-Aromatase | 0.218 |
| Antiviral | Yes |
| Prediction | 0.650373 |